Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$1.61B |
| 2 |
Abbott
ABT
|
+$1.02B |
| 3 |
British American Tobacco
BTI
|
+$1B |
| 4 |
GE Aerospace
GE
|
+$961M |
| 5 |
AbbVie
ABBV
|
+$818M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$2.61B |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$1.97B |
| 3 |
VALE.P
Vale S A
VALE.P
|
+$1.39B |
| 4 |
Texas Instruments
TXN
|
+$1.02B |
| 5 |
Boeing
BA
|
+$981M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.18% |
| 2 | Technology | 15.85% |
| 3 | Consumer Discretionary | 11.67% |
| 4 | Financials | 11.33% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Alexandria Real Estate Equities
ARE
$8.39B
| $58.4M | 0.02% |
490,491
| – | – |
|
|
PPL
327
PPL Corp
PPL
$26.9B
| $57.8M | 0.02% |
1,522,150
| – | – |
|
328
BP
BP
$110B
| $56.3M | 0.02% |
1,624,994
-27,987
| -2% | -$889K |
|
329
Hudbay
HBM
$11.9B
| $55.4M | 0.02% |
7,475,837
+761,000
| +11% | +$5.73M |
|
330
McKesson
MCK
$101B
| $53.8M | 0.02% |
350,000
-531,262
| -60% | -$82.9M |
|
331
Advance Auto Parts
AAP
$3.35B
| $53.6M | 0.02% |
+540,000
| New | +$54.5M |
|
332
Pfizer
PFE
$152B
| $53.5M | 0.02% |
1,581,000
| – | – |
|
333
Allegiant Air
ALGT
$2.36B
| $52.6M | 0.02% |
399,089
-148,089
| -27% | -$19.1M |
|
|
B
334
Barrick Mining
B
$66.6B
| $51.1M | 0.02% |
3,178,233
+2,646
| +0.1% | +$44.2K |
|
|
CRZO
335
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $50.5M | 0.02% |
2,950,270
| – | – |
|
336
Pampa Energía
PAM
$4.27B
| $49.5M | 0.02% |
761,025
-963,963
| -56% | -$56.5M |
|
337
Curtiss-Wright
CW
$26.3B
| $48.2M | 0.01% |
461,207
| – | – |
|
338
Sensata Technologies
ST
$6.68B
| $48.1M | 0.01% |
1,001,055
-6,436,359
| -87% | -$291M |
|
|
CY
339
DELISTED
Cypress Semiconductor
CY
| $48.1M | 0.01% |
3,200,000
-100,000
| -3% | -$1.4M |
|
340
CONMED
CNMD
$1.5B
| $46.2M | 0.01% |
881,000
| – | – |
|
|
DNR
341
DELISTED
Denbury Resources, Inc.
DNR
| $45.5M | 0.01% |
33,933,868
| – | – |
|
|
IDTI
342
DELISTED
Integrated Device Technology I
IDTI
| $45.4M | 0.01% |
+1,707,000
| New | +$43.3M |
|
343
Edwards Lifesciences
EW
$53.8B
| $43.8M | 0.01% |
1,201,158
-3
| -0% | -$114 |
|
|
VIA
344
DELISTED
Viacom Inc. Class A
VIA
| $43.7M | 0.01% |
1,190,363
+380,461
| +47% | +$14.8M |
|
345
NMI Holdings
NMIH
$3.39B
| $43.2M | 0.01% |
3,481,202
| – | – |
|
346
Intuit
INTU
$94.1B
| $42.6M | 0.01% |
300,000
| – | – |
|
347
Cathay General Bancorp
CATY
$4.32B
| $40.2M | 0.01% |
1,000,000
| – | – |
|
348
Eagle Bancorp
EGBN
$885M
| $38.4M | 0.01% |
+572,521
| New | +$35.9M |
|
|
CCI.PRA
349
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $37.5M | 0.01% |
+35,100
| New | +$38M |
|
|
X
350
DELISTED
US Steel
X
| $36.5M | 0.01% |
1,422,050
| – | – |
|
Similar funds
Capital Research Global Investors's Q3 2017 Portfolio in Review
As of Q3 2017, Capital Research Global Investors held 463 positions worth $331B, up 3.7% from $319B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors's Q3 2017 filing shows 32 new, 132 increased, 144 reduced and 31 closed positions. Its largest new stake was British American Tobacco: 15,546,114 shares worth $971M. The largest sale was Oracle, an estimated $2.61B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Capital Research Global Investors's largest Q3 2017 buy was British American Tobacco: 15,546,114 shares worth $971M.
- Capital Research Global Investors added most to Vale in Q3 2017, an estimated $1.61B increase.
- Capital Research Global Investors's biggest Q3 2017 reduction was Oracle, cutting an estimated $2.61B.
- Capital Research Global Investors fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.97B.
- Capital Research Global Investors's ten largest holdings make up 25% of its $331B portfolio in Q3 2017.
- Capital Research Global Investors opened 32 new positions and closed 31 in Q3 2017.
- Capital Research Global Investors's portfolio value rose 3.7% quarter-over-quarter to $331B.
Based on Capital Research Global Investors's 13F filing for Q3 2017, filed 14 Nov 2017.